833 related articles for article (PubMed ID: 25476204)
1. The Hippo signaling pathway in liver regeneration and tumorigenesis.
Hong L; Cai Y; Jiang M; Zhou D; Chen L
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
[TBL] [Abstract][Full Text] [Related]
2. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
3. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
Jang JW; Kim MK; Bae SC
Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
[TBL] [Abstract][Full Text] [Related]
4. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
5. The Hippo-YAP pathway: new connections between regulation of organ size and cancer.
Zhao B; Lei QY; Guan KL
Curr Opin Cell Biol; 2008 Dec; 20(6):638-46. PubMed ID: 18955139
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms of the mammalian Hippo signaling pathway.
Ji XY; Zhong G; Zhao B
Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
[TBL] [Abstract][Full Text] [Related]
7. Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration.
Grijalva JL; Huizenga M; Mueller K; Rodriguez S; Brazzo J; Camargo F; Sadri-Vakili G; Vakili K
Am J Physiol Gastrointest Liver Physiol; 2014 Jul; 307(2):G196-204. PubMed ID: 24875096
[TBL] [Abstract][Full Text] [Related]
8. The Hippo pathway in intestinal regeneration and disease.
Hong AW; Meng Z; Guan KL
Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):324-37. PubMed ID: 27147489
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
10. Hippo pathway - brief overview of its relevance in cancer.
Zygulska AL; Krzemieniecki K; Pierzchalski P
J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
[TBL] [Abstract][Full Text] [Related]
11. Hippo Signaling in the Liver Regulates Organ Size, Cell Fate, and Carcinogenesis.
Patel SH; Camargo FD; Yimlamai D
Gastroenterology; 2017 Feb; 152(3):533-545. PubMed ID: 28003097
[TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway.
Zhou X; Wang Z; Huang W; Lei QY
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):10-5. PubMed ID: 25491506
[TBL] [Abstract][Full Text] [Related]
13. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
14. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
Kodaka M; Hata Y
Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
[TBL] [Abstract][Full Text] [Related]
15. Structural dissection of Hippo signaling.
Shi Z; Jiao S; Zhou Z
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):29-38. PubMed ID: 25476203
[TBL] [Abstract][Full Text] [Related]
16. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
17. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
18. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
[TBL] [Abstract][Full Text] [Related]
19. The history and regulatory mechanism of the Hippo pathway.
Kim W; Jho EH
BMB Rep; 2018 Mar; 51(3):106-118. PubMed ID: 29397869
[TBL] [Abstract][Full Text] [Related]
20. Disease implications of the Hippo/YAP pathway.
Plouffe SW; Hong AW; Guan KL
Trends Mol Med; 2015 Apr; 21(4):212-22. PubMed ID: 25702974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]